Centennial Surgical Suture Ltd. announced the appointment of Ms. Sapna Mahtre as its new Chief Financial Officer and Key Managerial Personnel, effective August 14, 2026. Concurrently, Ms. Anuradha Kashikar has resigned from the same positions. Ms. Mahtre brings extensive experience to the role, having served the company since September 2001. The company’s Board of Directors meeting ratified these changes.
Key Leadership Change at Centennial Surgical Suture
Centennial Surgical Suture Ltd. has announced a significant change in its financial leadership. In a board meeting held on August 14, 2026, the company appointed Ms. Sapna Mahtre as the new Chief Financial Officer (CFO) and Key Managerial Personnel (KMP). This appointment is effective from August 14, 2026.
Resignation and Succession
The appointment follows the resignation of the previous CFO, Ms. Anuradha Kashikar, who has stepped down from her roles as Chief Financial Officer and Key Managerial Personnel. Her resignation is also effective from August 14, 2026. Ms. Kashikar has cited personal reasons for her departure, confirming that there are no other material reasons for her resignation beyond those stated in her email dated August 14, 2026.
Ms. Sapna Mahtre’s Background
Ms. Sapna Mahtre, the newly appointed CFO, has a long-standing association with Centennial Surgical Suture Ltd., having been employed with the company since September 2001. She previously served as the Chief Administrative Officer. In her new capacity, Ms. Mahtre will oversee the company’s entire finance and accounts functions. Her responsibilities will include financial planning and analysis, budgeting, cash-flow and treasury management, banking, taxation, internal financial controls, statutory and management reporting, audits, risk management, and regulatory filings. She holds a B. Com. and a Diploma in Financial Management (DFM).
Board Meeting Details
The Board of Directors of Centennial Surgical Suture Ltd. convened for their meeting at 5:00 p.m. and concluded at 5:30 p.m. on August 14, 2026. The meeting formally approved the aforementioned personnel changes, which are crucial for the company’s ongoing governance and financial operations.
Source: BSE
